ClinicalTrials.gov
public full text
Public Domain
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
The purpose of this trial is to identify a dose or doses of INS50589 intravenous infusion that are well-tolerated and which reduce postoperative bleeding and blood product transfusion.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection#846650
- Remimazolam Consumption: TCI vs. Manual Infusion#1032520
- A First-in-Human Single and Multiple Ascending Dose Study of MT-701#914658
- Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in Volunteers#1112085
- Heparinize ratlarda oluşturulan deneysel femoral arter kanama modelinde, lokal 'Microporous Polysaccharide Hemosphere (TraumaDex)' toz uygulamasının hemostaz süresine etkisi#1038172
Record · ID 1138114
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive